Pharma in Brief

DECEMBER 3, 2023

The original Regulations came into force on March 12, 1993, alongside changes to the Patent Act that abolished compulsory licenses for medicines and created an early-working exception to patent infringement. The first trial was decided in April 2020 (discussed here ). Evolution of the Regulations Coming into force (1993–1997).

Regulation 52

Regulation Compliance Medicine Manufacturing 52

XTalks

AUGUST 2, 2023

It contains the antiviral medications nirmatrelvir and ritonavir. This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. Toujeo generated Sanofi €1.12 Pfizer’s total global revenue from Paxlovid was $18.93 billion ($1.17

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

DECEMBER 23, 2020

24, 2020 /PRNewswire/ — COVAXX’s UB-612 is the first multitope, synthetic peptide-based COVID-19 vaccine candidate in clinical trials and it utilizes normal refrigeration (no freezing required) for distribution. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. .

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

The Pharma Data

DECEMBER 23, 2020

Under the signed license agreement, Aurobindo Pharma has obtained the exclusive rights to commercialize in India and to UNICEF and non-exclusive rights in other select emerging and developing markets. This vaccine has immense potential in eliminating shedding and hence containing the spread of the pandemic.”. About COVAXX.

Vaccination 52

Vaccination Vaccine Manufacturing Antibody 52